ACRIVON THERAPEUTICS INC's ticker is and the CUSIP is 004890109. A total of 19 filers reported holding ACRIVON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 1,652,605 | $19,038 | 5.21% |
| HealthCor Management, L.P. | 284,201 | $3,273,995 | 3.00% |
| RA Capital Management | 4,810,508 | $55,417,052 | 1.12% |
| Perceptive Advisors | 3,007,858 | $34,650,524 | 0.97% |
| NEA Management Company, LLC | 481,677 | $4,439,135 | 0.25% |
| DAFNA Capital Management LLC | 15,648 | $180,265 | 0.05% |
| MARSHALL WACE, LLP | 1,223,252 | $14,091,863 | 0.03% |
| FEDERATED HERMES, INC. | 823,300 | $9,484,416 | 0.03% |
| Citadel Advisors | 1,634,104 | $18,211,002 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 900,149 | $9,994,103 | 0.00% |